Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

Gilead Sciences (GILD) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 44 quarters since 2010. Compare with GILD stock chart to see long term trends.

GILD stock compared to

GILD Income Statement

Revenue, Net:7421000000
Revenue Per Share:5.9
Cost of Goods & Services Sold:1398000000
Gross Profit:5930000000
Selling, General & Admin Expense:1730000000
Research & Development Expense:1481000000
Total Operating Expenses:4770000000
Operating Income:2651000000
Income Taxes:270000000
Net Income:1558000000
Earnings Per Share, Basic:1.24
Shares Outstanding, Basic Avg:1257000000

GILD Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:837000000
Net Cash from Operations:1916000000
Repurchases/Buybacks Common Stock:0
Cash Dividends Paid:873000000
Net Cash from Financing Activities:131000000
Property, Plant & Equipment Purchases:181000000
Net Cash from Investing Activities:-8977000000
Net Change in Cash & Equivalents:-6889000000

GILD Balance Sheet

Cash and Cash Equivalents:5997000000
Short-Term Investments:1411000000
Accounts Receivable, Net:4892000000
Inventories:1683000000
Total Current Assets:15996000000
Property, Plant & Equipment, Net:4967000000
Total Assets:68407000000
Accounts Payable:844000000
Current Portion of Long-Term Debt:2757000000
Total Short-Term Liabilities:11397000000
Long Term Debt, Non-Current Portion:28645000000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
117,783,804 sh
1,949,534 sh
2%
$7,442,757
-$1,469,532
Vanguard Group Inc
102,722,460 sh
-2,090,879 sh
-2%
$6,491,033
-$1,573,306
Northern Trust Corp
15,853,066 sh
-228,140 sh
-1%
$1,001,755
-$235,534
Dodge & Cox
12,607,853 sh
15,341 sh
0%
$796,690
-$172,178
Legal & General Group Plc
9,104,511 sh
-44,489 sh
0%
$575,311
-$128,524
UBS Asset Management Americas Inc
8,604,194 sh
349,009 sh
4%
$543,699,018
-$91,454,917
Price T Rowe Associates Inc /Md/
8,082,091 sh
-764,496 sh
-9%
$510,707
-$169,949
FMR LLC
7,710,225 sh
-4,892,313 sh
-39%
$487,209
-$482,431
Renaissance Technologies LLC
7,651,879 sh
-1,249,368 sh
-14%
$483,522
-$201,340
Bank Of America Corp /De/
7,361,010 sh
6,703,010 sh
1019%
$465,142
$414,515
Royal Bank Of Canada
6,675,611 sh
6,505,611 sh
3827%
$421,831
$408,751
Charles Schwab Investment Management Inc
6,515,559 sh
-390,755 sh
-6%
$411,719
-$119,653
Morgan Stanley
6,017,516 sh
189,169 sh
3%
$380,248
-$68,185
Ameriprise Financial Inc
4,636,347 sh
141,898 sh
3%
$291,048
-$55,070
Amundi Pioneer Asset Management Inc
4,299,151 sh
590,331 sh
16%
$271,600
-$13,772
Invesco Ltd.
4,260,596 sh
-2,128,881 sh
-33%
$269,228
-$222,377
Credit Suisse Ag/
4,151,056 sh
3,931,056 sh
1787%
$262,306
$245,379
Parnassus Investments /Ca
3,525,824 sh
3,098 sh
0%
$222,797
-$48,242
Prudential Financial Inc
3,346,990 sh
1,166,443 sh
53%
$211,496
$43,725
Goldman Sachs Group Inc
3,295,587 sh
3,114,887 sh
1724%
$208,249
$194,346

Data imported from Gilead Sciences Inc SEC filings. Check original filings before making any investment decision.